Abstract
Accurate determination of microRNA expression levels is a prerequisite in using these small non-coding RNA molecules as novel biomarkers in disease diagnosis and prognosis. Quantitative PCR is the method of choice for measuring the expression levels of microRNAs. However, a major obstacle that affects the reliability of results is the lack of validated reference controls for data normalization. Various non-coding RNAs have previously been used as reference controls, but their use may lead to variations and lack of comparability of microRNA data among the studies. Despite the growing number of studies investigating microRNA profiles to discriminate between healthy and disease stages, robust reference controls for data normalization have so far not been established. In the present article, we provide an overview of different reference controls used in various diseases, and highlight the urgent need for the identification of suitable reference controls to produce reliable data. Our analysis shows, among others, that RNU6 is not an ideal normalizer in studies using patient material from different diseases. Finally, our article tries to disclose the challenges to find a reference control which is uniformly and stably expressed across all body tissues, fluids, and diseases.
Similar content being viewed by others
References
Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281–297
Sierzega M, Kaczor M, Kolodziejczyk P, Kulig J, Sanak M, Richter P (2017) Evaluation of serum microRNA biomarkers for gastric cancer based on blood and tissue pools profiling: the importance of miR-21 and miR-331. Br J Cancer 117(2):266
Lin H-M, Mahon KL, Spielman C, Gurney H, Mallesara G, Stockler MR et al (2017) Phase 2 study of circulating microRNA biomarkers in castration-resistant prostate cancer. Br J Cancer 116(8):1002
Kahraman M, Röske A, Laufer T, Fehlmann T, Backes C, Kern F et al (2018) MicroRNA in diagnosis and therapy monitoring of early-stage triple-negative breast cancer. Sci Rep 8(1):11584
Schwarzenbach H, Nishida N, Calin GA, Pantel K (2014) Clinical relevance of circulating cell-free microRNAs in cancer. Nat Rev Clin Oncol 11(3):145
Cheng L, Doecke JD, Sharples R, Villemagne VL, Fowler CJ, Rembach A et al (2015) Prognostic serum miRNA biomarkers associated with Alzheimer’s disease shows concordance with neuropsychological and neuroimaging assessment. Mol Psychiatry 20(10):1188
Roser AE, Gomes LC, Schünemann J, Maass F, Lingor P (2018) Circulating miRNAs as diagnostic biomarkers for Parkinson’s disease. Front Neurosci 12:625
Zhou S-S, Jin J-P, Wang J-Q, Zhang Z-G, Freedman JH, Zheng Y et al (2018) miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges. Acta Pharmacol Sin 39(7):1073
Li H, Liu J, Chen J, Wang H, Yang L, Chen F et al (2018) A serum microRNA signature predicts trastuzumab benefit in HER2-positive metastatic breast cancer patients. Nat Commun 9(1):1614
Bartels CL, Tsongalis GJ (2009) MicroRNAs: novel biomarkers for human cancer. Clin Chem 55(4):623–631
Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C T method. Nat Protoc 3(6):1101
Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M et al (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55(4):611–622
Schwarzenbach H, da Silva AM, Calin G, Pantel K (2015) Data normalization strategies for microRNA quantification. Clin Chem 61(11):1333–1342
Hong TH, Park IY (2014) MicroRNA expression profiling of diagnostic needle aspirates from surgical pancreatic cancer specimens. Ann Surg Treat Res 87(6):290–297
Du Rieu MC, Torrisani J, Selves J, Al Saati T, Souque A, Dufresne M et al (2010) MicroRNA-21 is induced early in pancreatic ductal adenocarcinoma precursor lesions. Clin Chem 56(4):603–612
Tiberio P, Callari M, Angeloni V, Daidone MG, Appierto V (2015) Challenges in using circulating miRNAs as cancer biomarkers. BioMed Res Int 2015:731479
Schwarzenbach H (2017) Methods for quantification and characterization of microRNAs in cell-free plasma/serum, normal exosomes and tumor-derived exosomes. Transl Cancer Res 7(2):S253–S263
Ibberson D, Benes V, Muckenthaler MU, Castoldi M (2009) RNA degradation compromises the reliability of microRNA expression profiling. BMC Biotechnol 9(1):102
Shingara J, Keiger K, Shelton J, Laosinchai-Wolf W, Powers P, Conrad R et al (2005) An optimized isolation and labeling platform for accurate microRNA expression profiling. RNA 11(9):1461–1470
Kim D-J, Linnstaedt S, Palma J, Park JC, Ntrivalas E, Kwak-Kim JY et al (2012) Plasma components affect accuracy of circulating cancer-related microRNA quantitation. J Mol Diagn 14(1):71–80
Benes V, Castoldi M (2010) Expression profiling of microRNA using real-time quantitative PCR, how to use it and what is available. Methods 50(4):244–249
Pritchard CC, Cheng HH, Tewari M (2012) MicroRNA profiling: approaches and considerations. Nat Rev Genet 13(5):358
Haider BA, Baras AS, McCall MN, Hertel JA, Cornish TC, Halushka MK (2014) A critical evaluation of microRNA biomarkers in non-neoplastic disease. PLoS One 9(2):e89565
Marabita F, de Candia P, Torri A, Tegner J, Abrignani S, Rossi RL (2015) Normalization of circulating microRNA expression data obtained by quantitative real-time RT-PCR. Brief Bioinform 17(2):204–212
Kiss T (2002) Small nucleolar RNAs: an abundant group of noncoding RNAs with diverse cellular functions. Cell 109(2):145–148
Matera AG, Terns RM, Terns MP (2007) Non-coding RNAs: lessons from the small nuclear and small nucleolar RNAs. Nat Rev Mol Cell Biol 8(3):209
Qi R, Weiland M, Gao XH, Zhou L, Mi QS (2012) Identification of endogenous normalizers for serum microRNAs by microarray profiling: U6 small nuclear RNA is not a reliable normalizer. Hepatology 55(5):1640–1642
Zhu H-T, Dong Q-Z, Wang G, Zhou H-J, Ren N, Jia H-L et al (2012) Identification of suitable reference genes for qRT-PCR analysis of circulating microRNAs in hepatitis B virus-infected patients. Mol Biotechnol 50(1):49–56
Li Y, Zhang L, Liu F, Xiang G, Jiang D, Pu X (2015) Identification of endogenous controls for analyzing serum exosomal miRNA in patients with hepatitis B or hepatocellular carcinoma. Dis Markers. https://doi.org/10.1155/2015/893594
Tang G, Shen X, Lv K, Wu Y, Bi J, Shen Q (2015) Different normalization strategies might cause inconsistent variation in circulating microRNAs in patients with hepatocellular carcinoma. Med Sci Monit 21:617
Benz F, Roderburg C, Cardenas DV, Vucur M, Gautheron J, Koch A et al (2013) U6 is unsuitable for normalization of serum miRNA levels in patients with sepsis or liver fibrosis. Exp Mol Med 45(9):e42
Madadi S, Soleimani M (2019) The crucial need of internal control validation in the normalization of circulating microRNAs. Dig Liver Dis 51:610–611
Lange T, Stracke S, Rettig R, Lendeckel U, Kuhn J, Schlüter R et al (2017) Identification of miR-16 as an endogenous reference gene for the normalization of urinary exosomal miRNA expression data from CKD patients. PLoS One 12(8):e0183435
Ling T-Y, Wang X-L, Chai Q, Lau T-W, Koestler CM, Park SJ et al (2013) Regulation of the SK3 channel by microRNA-499—potential role in atrial fibrillation. Heart Rhythm 10(7):1001–1009
Masè M, Grasso M, Avogaro L, D’Amato E, Tessarolo F, Graffigna A et al (2017) Selection of reference genes is critical for miRNA expression analysis in human cardiac tissue. A focus on atrial fibrillation. Sci Rep 7:41127
Zhang Y, Tang W, Peng L, Tang J, Yuan Z (2016) Identification and validation of microRNAs as endogenous controls for quantitative polymerase chain reaction in plasma for stable coronary artery disease. Cardiol J 23(6):694–703
Wang X, Zhang X, Yuan J, Wu J, Deng X, Peng J et al (2018) Evaluation of the performance of serum miRNAs as normalizers in microRNA studies focused on cardiovascular disease. J Thorac Dis 10(5):2599–2607
Solayman MHM, Langaee T, Patel A, El-Wakeel L, El-Hamamsy M, Badary O et al (2016) Identification of suitable endogenous normalizers for qRT-PCR analysis of plasma microRNA expression in essential hypertension. Mol Biotechnol 58(3):179–187
Barry SE, Chan B, Ellis M, Yang Y, Plit ML, Guan G et al (2015) Identification of miR-93 as a suitable miR for normalizing miRNA in plasma of tuberculosis patients. J Cell Mol Med 19(7):1606–1613
Liu X, Zhang L, Cheng K, Wang X, Ren G, Xie P (2014) Identification of suitable plasma-based reference genes for miRNAome analysis of major depressive disorder. J Affect Disord 163:133–139
Serafin A, Foco L, Blankenburg H, Picard A, Zanigni S, Zanon A et al (2014) Identification of a set of endogenous reference genes for miRNA expression studies in Parkinson’s disease blood samples. BMC Res Notes 7(1):715
Margis R, Margis R, Rieder CR (2011) Identification of blood microRNAs associated to Parkinsońs disease. J Biotechnol 152(3):96–101
Martins M, Rosa A, Guedes LC, Fonseca BV, Gotovac K, Violante S et al (2011) Convergence of miRNA expression profiling, α-synuclein interacton, and GWAS in Parkinson’s disease. PLoS One 6(10):e25443
Eriksen AHM, Andersen RF, Pallisgaard N, Sørensen FB, Jakobsen A, Hansen TF (2016) MicroRNA expression profiling to identify and validate reference genes for the relative quantification of microRNA in rectal cancer. PLoS One 11(3):e0150593
Zheng G, Wang H, Zhang X, Yang Y, Wang L, Du L et al (2013) Identification and validation of reference genes for qPCR detection of serum microRNAs in colorectal adenocarcinoma patients. PLoS One 8(12):e83025
Iwaya T, Yokobori T, Nishida N, Kogo R, Sudo T, Tanaka F et al (2012) Downregulation of miR-144 is associated with colorectal cancer progression via activation of mTOR signaling pathway. Carcinogenesis 33(12):2391–2397
Niu Y, Wu Y, Huang J, Li Q, Kang K, Qu J et al (2016) Identification of reference genes for circulating microRNA analysis in colorectal cancer. Sci Rep 6:35611
Chang KH, Mestdagh P, Vandesompele J, Kerin MJ, Miller N (2010) MicroRNA expression profiling to identify and validate reference genes for relative quantification in colorectal cancer. BMC Cancer 10(1):173
Bandrés E, Cubedo E, Agirre X, Malumbres R, Zarate R, Ramirez N et al (2006) Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer 5(1):29
Madadi S, Soleimani M (2019) Comparison of miR-16 and cel-miR-39 as reference controls for serum miRNA normalization in colorectal cancer. J Cell Biochem 120:4802–4803
Danese E, Minicozzi A, Benati M, Paviati E, Lima-Oliveira G, Gusella M et al (2017) Reference miRNAs for colorectal cancer: analysis and verification of current data. Sci Rep 7(1):8413
McDermott AM, Kerin MJ, Miller N (2013) Identification and validation of miRNAs as endogenous controls for RQ-PCR in blood specimens for breast cancer studies. PLoS One 8(12):e83718
Davoren PA, McNeill RE, Lowery AJ, Kerin MJ, Miller N (2008) Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer. BMC Mol Biol 9(1):76
Appaiah HN, Goswami CP, Mina LA, Badve S, Sledge GW, Liu Y et al (2011) Persistent upregulation of U6: SNORD44 small RNA ratio in the serum of breast cancer patients. Breast Cancer Res 13(5):R86
Stückrath I, Rack B, Janni W, Jäger B, Pantel K, Schwarzenbach H (2015) Aberrant plasma levels of circulating miR-16, miR-107, miR-130a and miR-146a are associated with lymph node metastasis and receptor status of breast cancer patients. Oncotarget 6(15):13387
Madadi S, Soleimani M (2019) Evaluation of miR-16 as an internal control in the patients with breast cancer. Hum Pathol 85:329
McDermott AM, Miller N, Wall D, Martyn LM, Ball G, Sweeney KJ et al (2014) Identification and validation of oncologic miRNA biomarkers for luminal A-like breast cancer. PLoS One 9(1):e87032
Lou G, Ma N, Xu Y, Jiang L, Yang J, Wang C et al (2015) Differential distribution of U6 (RNU6-1) expression in human carcinoma tissues demonstrates the requirement for caution in the internal control gene selection for microRNA quantification. Int J Mol Med 36(5):1400–1408
Gee H, Buffa F, Camps C, Ramachandran A, Leek R, Taylor M et al (2011) The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis. Br J Cancer 104(7):1168
Ratert N, Meyer H-A, Jung M, Mollenkopf H-J, Wagner I, Miller K et al (2012) Reference miRNAs for miRNAome analysis of urothelial carcinomas. PLoS One 7(6):e39309
Adam L, Wszolek MF, Liu C-G, Jing W, Diao L, Zien A et al (eds) (2013) Plasma microRNA profiles for bladder cancer detection. Urologic Oncology: Seminars and Original Investigations. Elsevier, Amsterdam
Wang L, Liu Y, Du L, Li J, Jiang X, Zheng G et al (2015) Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer. Mol Med Rep 12(1):615–622
Wotschofsky Z, Meyer H-A, Jung M, Fendler A, Wagner I, Stephan C et al (2011) Reference genes for the relative quantification of microRNAs in renal cell carcinomas and their metastases. Anal Biochem 417(2):233–241
Iwamoto H, Kanda Y, Sejima T, Osaki M, Okada F, Takenaka A (2014) Serum miR-210 as a potential biomarker of early clear cell renal cell carcinoma. Int J Oncol 44(1):53–58
Sanders I, Holdenrieder S, Walgenbach-Brünagel G, von Ruecker A, Kristiansen G, Müller SC et al (2012) Evaluation of reference genes for the analysis of serum miRNA in patients with prostate cancer, bladder cancer and renal cell carcinoma. Int J Urol 19(11):1017–1025
Shen Y, Li Y, Ye F, Wang F, Wan X, Lu W et al (2011) Identification of miR-23a as a novel microRNA normalizer for relative quantification in human uterine cervical tissues. Exp Mol Med 43(6):358
Leitao MCG, Coimbra EC, de Lima RCP, de Lima Guimaraes M, de Andrade Heraclio S, Neto JCS et al (2014) Quantifying mRNA and microRNA with qPCR in cervical carcinogenesis: a validation of reference genes to ensure accurate data. PLoS One 9(11):e111021
Babion I, Snoek BC, van de Wiel MA, Wilting SM, Steenbergen RD (2017) A strategy to find suitable reference genes for miRNA quantitative PCR analysis and its application to cervical specimens. J Mol Diagn 19(5):625–637
Hansen CN, Ketabi Z, Rosenstierne MW, Palle C, Boesen HC, Norrild B (2009) Expression of CPEB, GAPDH and U6snRNA in cervical and ovarian tissue during cancer development. APMIS 117(1):53–59
Li Y, Xiang GM, Liu LL, Liu C, Liu F, Jiang DN et al (2015) Assessment of endogenous reference gene suitability for serum exosomal microRNA expression analysis in liver carcinoma resection studies. Mol Med Rep 12(3):4683–4691
Ding X, Ding J, Ning J, Yi F, Chen J, Zhao D et al (2012) Circulating microRNA-122 as a potential biomarker for liver injury. Mol Med Rep 5(6):1428–1432
Schaefer A, Jung M, Miller K, Lein M, Kristiansen G, Erbersdobler A et al (2010) Suitable reference genes for relative quantification of miRNA expression in prostate cancer. Exp Mol Med 42(11):749
Carlsson J, Helenius G, Karlsson M, Lubovac Z, Andrén O, Olsson B et al (2010) Validation of suitable endogenous control genes for expression studies of miRNA in prostate cancer tissues. Cancer Genet Cytogenet 202(2):71–75
Egidi MG, Cochetti G, Guelfi G, Zampini D, Diverio S, Poli G et al (2015) Stability assessment of candidate reference genes in urine sediment of prostate cancer patients for miRNA applications. Dis Markers. https://doi.org/10.1155/2015/973597
Chen L, Jin Y, Wang L, Sun F, Yang X, Shi M et al (2017) Identification of reference genes and miRNAs for qRT-PCR in human esophageal squamous cell carcinoma. Med Oncol 34(1):2
Popov A, Szabo A, Mandys V (2015) Small nucleolar RNA U91 is a new internal control for accurate microRNAs quantification in pancreatic cancer. BMC Cancer 15(1):774
Que R, Ding G, Chen J, Cao L (2013) Analysis of serum exosomal microRNAs and clinicopathologic features of patients with pancreatic adenocarcinoma. World J Surg Oncol 11(1):219
Madadi S, Soleimani M (2019) Plasma microRNA investigation: the impact of selecting a suitable internal control on data normalization in pancreatic cancer. J Hepato-Biliary-Pancreatic Sci 26(2):E1
Sperveslage J, Hoffmeister M, Henopp T, Klöppel G, Sipos B (2014) Establishment of robust controls for the normalization of miRNA expression in neuroendocrine tumors of the ileum and pancreas. Endocrine 46(2):226–230
Song J, Bai Z, Han W, Zhang J, Meng H, Bi J et al (2012) Identification of suitable reference genes for qPCR analysis of serum microRNA in gastric cancer patients. Dig Dis Sci 57(4):897–904
Torres A, Torres K, Wdowiak P, Paszkowski T, Maciejewski R (2013) Selection and validation of endogenous controls for microRNA expression studies in endometrioid endometrial cancer tissues. Gynecol Oncol 130(3):588–594
Huber PJ (2011) Robust statistics. Springer, Berlin
Schuirmann D (ed) (1981) On hypothesis-testing to determine if the mean of a normal-distribution is contained in a known interval. Biometrics. International Biometric Society, Washington DC
Bignotti E, Calza S, Tassi RA, Zanotti L, Bandiera E, Sartori E et al (2016) Identification of stably expressed reference small non-coding RNA s for micro RNA quantification in high-grade serous ovarian carcinoma tissues. J Cell Mol Med 20(12):2341–2348
Hu J, Wang Z, Liao BY, Yu L, Gao X, Lu S et al (2014) Human miR-1228 as a stable endogenous control for the quantification of circulating microRNAs in cancer patients. Int J Cancer 135(5):1187–1194
Peltier HJ, Latham GJ (2008) Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA 14(5):844–852
Rice J, Roberts H, Rai SN, Galandiuk S (2015) Housekeeping genes for studies of plasma microRNA: a need for more precise standardization. Surgery 158(5):1345–1351
Chen X, Liang H, Guan D, Wang C, Hu X, Cui L et al (2013) A combination of Let-7d, Let-7g and Let-7i serves as a stable reference for normalization of serum microRNAs. PLoS One 8(11):e79652
Hu Z, Dong J, Wang L-E, Ma H, Liu J, Zhao Y et al (2012) Serum microRNA profiling and breast cancer risk: the use of miR-484/191 as endogenous controls. Carcinogenesis 33(4):828–834
Xiang M, Zeng Y, Yang R, Xu H, Chen Z, Zhong J et al (2014) U6 is not a suitable endogenous control for the quantification of circulating microRNAs. Biochem Biophys Res Commun 454(1):210–214
Inada K, Okoshi Y, Cho-Isoda Y, Ishiguro S, Suzuki H, Oki A et al (2018) Endogenous reference RNAs for microRNA quantitation in formalin-fixed, paraffin-embedded lymph node tissue. Sci Rep 8(1):5918
Lamba V, Ghodke-Puranik Y, Guan W, Lamba JK (2014) Identification of suitable reference genes for hepatic microRNA quantitation. BMC Res Notes 7(1):129
Armand-Labit V, Pradines A (2017) Circulating cell-free microRNAs as clinical cancer biomarkers. Biomol Concepts 8(2):61–81
Stevic I, Müller V, Weber K, Fasching PA, Karn T, Marmé F et al (2018) Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial. BMC Med 16(1):179
Kuhlmann JD, Baraniskin A, Hahn SA, Mosel F, Bredemeier M, Wimberger P et al (2014) Circulating U2 small nuclear RNA fragments as a novel diagnostic tool for patients with epithelial ovarian cancer. Clin Chem 60(1):206–213
Liu M, Liu J, Wang L, Wu H, Zhou C, Zhu H et al (2014) Association of serum microRNA expression in hepatocellular carcinomas treated with transarterial chemoembolization and patient survival. PLoS One 9(10):e109347
Anadol E, Schierwagen R, Elfimova N, Tack K, Schwarze-Zander C, Eischeid H et al (2015) Circulating microRNAs as a marker for liver injury in human immunodeficiency virus patients. Hepatology 61(1):46–55
Sourvinou IS, Markou A, Lianidou ES (2013) Quantification of circulating miRNAs in plasma: effect of preanalytical and analytical parameters on their isolation and stability. J Mol Diagn 15(6):827–834
Luque A, Farwati A, Crovetto F, Crispi F, Figueras F, Gratacós E et al (2014) Usefulness of circulating microRNAs for the prediction of early preeclampsia at first-trimester of pregnancy. Sci Rep 4:4882
Zhang J, Raju GS, Chang DW, Lin SH, Chen Z, Wu X (2018) Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer. Cancer 124(4):785–796
Xu Y-F, Hannafon BN, Zhao YD, Postier RG, Ding W-Q (2017) Plasma exosome miR-196a and miR-1246 are potential indicators of localized pancreatic cancer. Oncotarget 8(44):77028
Sohn W, Kim J, Kang SH, Yang SR, Cho J-Y, Cho HC et al (2015) Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma. Exp Mol Med 47(9):e184
Appourchaux K, Dokmak S, Resche-Rigon M, Treton X, Lapalus M, Gattolliat C-H et al (2016) MicroRNA-based diagnostic tools for advanced fibrosis and cirrhosis in patients with chronic hepatitis B and C. Sci Rep 6:34935
Meng X, Müller V, Milde-Langosch K, Trillsch F, Pantel K, Schwarzenbach H (2016) Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer. Oncotarget 7(13):16923
Meng X, Joosse SA, Müller V, Trillsch F, Milde-Langosch K, Mahner S et al (2015) Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients. Br J Cancer 113(9):1358
Li J, Wang Y, Yu W, Chen J, Luo J (2011) Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance. Biochem Biophys Res Commun 406(1):70–73
Sode J, Krintel SB, Carlsen AL, Hetland ML, Johansen JS, Hørslev-Petersen K et al (2018) Plasma microRNA profiles in patients with early rheumatoid arthritis responding to adalimumab plus methotrexate vs methotrexate alone: a placebo-controlled clinical trial. J Rheumatol 45(1):53–61
Madadi S, Soleimani M (2019) Study of serum microRNA expression in an amyotrophic lateral sclerosis patient: challenge of selecting suitable internal control for normalization. Muscle Nerve 59:E2–E3
Madadi S, Soleimani M (2018) U6 as a microRNA normalizer in serum of patients with hepatocellular carcinoma. Ann Clin Biochem 2018:4563218808820
Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A et al (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3(7):research0034.1
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Madadi, S., Schwarzenbach, H., Lorenzen, J. et al. MicroRNA expression studies: challenge of selecting reliable reference controls for data normalization. Cell. Mol. Life Sci. 76, 3497–3514 (2019). https://doi.org/10.1007/s00018-019-03136-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00018-019-03136-y